SNDX
SNDX
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
4
$242K
Insider Sales
17
$6.86M
Total Volume
$7.10M
21 transactions
Net Activity
$6.61M
Net selling
Sentiment Rating
Neutral / BalancedCEO Conviction Index
Liquidating / Profit Taking
Key Drivers
- •Heavy distribution: sales represent 97% of total transaction value.
- •Cluster buying: 4 unique insiders purchased shares, showing strong alignment.
- •CEO selling activity detected. Often driven by option expiration or diversification plans.
- •CFO buying activity detected. Statistical studies show CFO purchases have high predictive power due to their direct visibility into balance sheet details.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Metzger Michael A
CEO
$4.40M total
Botwood Nicholas A.J.
Head of R, D, CMO
$1.29M total
Podlesak Dennis
Dir
$989K total
Goldan Keith A.
CFO
$208K total
Katkin Keith
Dir
$91K total
Quick Actions
SNDX has an insider buy conviction of 3%, compared to the Unknown sector buy average of 6%. SNDX ranks #475 in insider activity out of 563 tracked companies in its industry.
Over the last 90 days, corporate insiders at SNDX (SNDX) engaged in a total of 21 transactions reported via SEC Form 4 filings. Among these, 4 were open-market purchases and 17 were sales. The total volume of insider trading reached $7.10M.
The net insider activity for SNDX shows a net selling bias of $6.61M. This activity represents a 3% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Metzger Michael A (CEO), who traded 157.3K shares valued at $2.58M on Sep 8, 2025.
Syndax Pharmaceuticals (SNDX) Stock May Be Rich After Revuforj Award Win
Syndax (SNDX) Sales Nearly Doubled, So Why Did The Stock Fall?
Syndax Pharmaceuticals (SNDX) Stock Price, Chart & Analysis
SNDX - Syndax Pharmaceuticals Inc Stock Price and Quote
Syndax Pharmaceuticals (SNDX) Missed On Q3 Results, Is The 65% Undervaluation Case Still Intact?
Syndax Pharmaceuticals (SNDX) Stock May Trade At A Premium After A 38% Fall
FAQs About SNDX Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for SNDX.